U.S. Software Stock News

If you are wondering whether Vital Farms at around US$27.71 is priced attractively today, the key question is whether the current share price lines up with the underlying business value. The stock has been choppy, with a 5.8% gain over the last 7 days, a 9.4% decline over 30 days, a 7.1% decline year to date, a 21.8% decline over 1 year, but an 82.4% return over 3 years and a 2.7% decline over 5 years. Recent news coverage has focused on Vital Farms' position in the pasture raised egg and...

Conduent (CNDT) has just posted its FY 2025 third quarter numbers, with revenue of US$767 million and a net income loss of US$48 million, translating to basic EPS of a US$0.31 loss. Over recent quarters the company has seen revenue move from US$828 million and EPS of US$1.09 in Q2 2024 to US$751 million and EPS of a US$0.33 loss in Q1 2025, before landing at US$767 million and EPS of a US$0.31 loss in Q3 2025. Trailing twelve month figures now sit at US$3.1 billion of revenue and an EPS loss...

TransUnion (TRU) just posted its latest FY 2025 numbers with Q3 revenue of US$1.2b, basic EPS of US$0.50 and net income excluding extra items of US$96.6m, set against trailing 12 month revenue of US$4.4b and EPS of US$2.16. These figures reflect an 87.5% year over year earnings jump and a move in net margin from 5.5% to 9.5%. The company has seen quarterly revenue range from US$1.0b in Q4 2024 to US$1.2b in Q3 2025. Over the same period, quarterly EPS moved from US$0.34 to US$0.76 and then...

McGraw Hill (MH) just posted Q3 2026 results with revenue of US$434.2 million, a basic EPS loss of US$0.11, and net income loss of US$20.2 million. Over recent quarters, the company has seen revenue move from US$416.5 million in Q3 2025 to US$473.3 million in Q4 2025, then to US$535.7 million in Q1 2026 and US$669.2 million in Q2 2026, while EPS swung between a loss of US$0.32 in Q3 2025, a deeper loss of US$0.94 in Q4 2025, a marginal profit of US$0.00 in Q1 2026, and a profit of US$0.57 in...

Fastly (FSLY) has wrapped up FY 2025 with fourth quarter revenue of US$172.6 million and a basic EPS loss of US$0.10, setting the tone for another year where top line progress sits alongside ongoing red ink. The company has seen quarterly revenue move from US$140.6 million in Q4 2024 to US$172.6 million in Q4 2025, while basic EPS losses shifted from US$0.23 to US$0.10 over the same period. Over the trailing 12 months it generated US$624.0 million of revenue with a basic EPS loss of US$0.83...

If you are wondering whether LifeStance Health Group is attractively priced or still carrying a premium, you are not alone. This article is built to unpack what the current share price might be implying. The stock last closed at US$6.92, with a recent 7 day return of 5.8%, a 30 day return of 4.6% decline, and year to date and 1 year returns of 0.6% decline and 13.4% decline respectively, set against a 3 year return of 23.1%. Recent news coverage around LifeStance Health Group has focused on...

If you are trying to figure out whether Excelerate Energy is priced attractively right now, it helps to step back and look at both the recent share moves and what they might be saying about expectations. The stock last closed at US$40.36, with returns of 12.7% over 7 days, 27.8% over 30 days, 42.4% year to date, and 36.9% over the past year. These moves may have changed how investors think about its potential and its risks. Recent news flow around Excelerate Energy has focused on its...

GCI Liberty (GLIB.A) has just posted a tough third quarter for FY 2025, with revenue of US$257 million alongside a basic EPS loss of US$13.34 and a net loss of US$387 million, setting a cautious tone around profitability. Over the past few quarters, the company has seen revenue move around the US$260 million mark, from US$262 million in Q3 2024 to US$266 million in Q1 2025 and US$261 million in Q2 2025. Basic EPS shifted from US$0.72 in Q3 2024 to US$1.22 in Q1 2025 and US$0.94 in Q2 2025...

LightPath Technologies (LPTH) just posted its latest quarterly update with Q2 2026 revenue of about US$15.1 million and a basic EPS loss of US$0.07, alongside trailing twelve month revenue of US$43.9 million and a basic EPS loss of US$0.39. Over recent periods the company has seen revenue move from US$8.6 million in Q4 2024 to US$12.2 million in Q4 2025. Quarterly EPS losses ranged between US$0.04 and US$0.16, which gives you a sense of how the top line has scaled against still pressured...

How CoreCivic’s FY 2025 Numbers Set the Stage for the Story Ahead CoreCivic (CXW) closed FY 2025 with fourth quarter revenue of US$604.0 million and basic EPS of US$0.26, while trailing twelve month revenue came in at about US$2.2 billion and EPS at US$1.09, framing a year where reported earnings grew 69.2% and five year average earnings growth was 33.1% per year. The company has seen revenue move from US$479.3 million in Q4 2024 to US$604.0 million in Q4 2025. Basic EPS over those quarters...

Nabors Industries (NBR) has just posted a sharp swing in its FY 2025 third quarter results, with revenue at US$818.2 million and Basic EPS of US$18.25, alongside trailing 12 month Basic EPS of US$15.31 supported by a one off gain of US$449.0 million and net income of US$183.2 million. The company has seen quarterly revenue move from US$734.8 million in Q2 2024 to US$832.8 million in Q2 2025, while quarterly Basic EPS ranged from a loss of US$6.86 in Q3 2024 to a profit of US$18.25 in Q3 2025...

Leggett & Platt (LEG) closed out FY 2025 with Q4 revenue of US$938.6 million and basic EPS of US$0.18. On a trailing twelve month basis, the company generated US$4.1 billion of revenue and EPS of US$1.70 as it moved back into positive net income of US$235.4 million. Over recent quarters, revenue has ranged from US$1.1 billion in Q2 2025 to US$938.6 million in Q4 2025. Quarterly EPS moved from US$0.10 in Q4 2024 to US$0.92 in Q3 2025 before landing at US$0.18 in the latest quarter, giving...

Nova (NVMI) has put up another busy quarter, with Q3 FY 2025 revenue of US$224.6 million and basic EPS of US$2.05, backed by trailing 12 month revenue of US$852.7 million and EPS of US$8.30 that sit on top of solid reported earnings growth figures in the supplied data. The company has seen revenue move from US$178.9 million in Q3 FY 2024 to US$224.6 million in Q3 FY 2025, while basic EPS over that span went from US$1.76 to US$2.05. With net margin reported at 28.7% and described as slightly...

If you are looking at Tennant and wondering whether the current share price still offers value, you are not alone. The stock last closed at US$81.61, with returns of 1.0% over 7 days, 4.5% over 30 days, 10.3% year to date, and a 6.1% decline over the past year, which may have investors reassessing both its potential and its risks. Recent news coverage has focused on Tennant's position in the capital goods space and how investors are weighing its long term prospects against past share price...

Avista (NYSE:AVA) has declared an increase to its quarterly dividend, extending its streak of annual dividend growth to 24 consecutive years. The company also released a new long term resource plan that includes major investments in clean energy projects and grid reliability initiatives. Both moves were announced together, underscoring Avista's focus on shareholder payouts alongside system upgrades and cleaner power sources. Avista enters this phase of capital planning with its shares at...

Curtiss-Wright (CW) has wrapped up FY 2025 with fourth quarter revenue of US$947 million and basic EPS of US$3.71, alongside net income of US$137 million as investors weigh what these numbers say about the full year. Over recent periods, the company has seen quarterly revenue range from US$806 million to US$947 million and basic EPS move from US$2.69 to US$3.71, while trailing twelve month EPS stands at US$12.94 and revenue at about US$3.5 billion. This sets the backdrop for how you read this...

Solstice Advanced Materials (SOLS) capped FY 2025 with Q4 revenue of US$987 million and basic EPS of US$0.26, alongside trailing twelve month revenue of US$3.9 billion and EPS of US$1.49 that sits against a 3.1% revenue increase and a trailing net margin that has moved from 15.8% to 6.1% over the past year. The company has seen revenue move from US$3.6 billion to around US$3.9 billion on a trailing basis while net income shifted from US$621 million to US$237 million, setting up a picture...

Copa Holdings (NYSE:CPA) has put up another solid quarter, with Q3 FY 2025 revenue of US$913.1 million and basic EPS of US$4.20, supported by net income of US$173.4 million. The company has seen revenue move from US$854.7 million in Q3 FY 2024 to US$913.1 million in Q3 FY 2025, while basic EPS over the same quarters went from US$3.50 to US$4.20, setting the stage for investors to focus on how its passenger load factor and revenue yield are feeding into sustaining margins. See our full...

AMC Networks (AMCX) closed FY 2025 with Q4 revenue of US$594.8 million and basic EPS of a US$1.26 loss, while trailing twelve month EPS stood at US$2.01 on total revenue of US$2.3 billion and net income of US$89.4 million. Over recent quarters the company has seen revenue range from US$555.2 million to US$600.0 million, with quarterly EPS moving from US$0.40 in Q1 2025 to US$1.73 in Q3 2025 before the Q4 loss. This sets up a picture of earnings that have turned positive on a full year basis...

Aeluma (ALMU) has just posted its Q2 2026 scorecard, with Q1 2026 revenue at about US$1.4 million and a basic EPS loss of US$0.09, alongside trailing twelve month revenue of US$5.6 million and a TTM basic EPS loss of US$0.27 that keeps the story firmly in loss making territory. The company has seen quarterly revenue move from US$0.28 million in Q4 2024 to US$1.39 million in Q1 2026, while quarterly EPS has ranged between a loss of US$0.24 and a profit of US$0.12 over that period, pointing to...

Event context and recent stock performance Upstream Bio (UPB) has drawn investor attention after a sharp move in its share price, with the stock down about 13% on the day and weaker over the past week and month. Those short term moves come against a stronger past year, where total return sits around 75%. This raises questions about how investors are weighing the company’s clinical stage respiratory pipeline in relation to its financial profile and recent trading volatility. See our latest...

Pacira BioSciences (NASDAQ:PCRX) has had a rough three months with its share price down 8.6%. It seems that the market...

JM Group (JMG) has put fresh numbers on the table for FY 2025, with second half revenue of HK$122.0 million and basic EPS of HK$0.39, while the trailing twelve months show revenue of HK$269.4 million and EPS of HK$1.17 backed by net income of HK$18.7 million. The company has seen revenue move from HK$92.1 million and EPS of HK$0.12 in 2H 2024 to HK$147.3 million and EPS of HK$0.78 in 1H 2025, before landing at the latest half year figures. Over the past year, earnings growth of 165.4% has...

The Sprinklr, Inc. ( NYSE:CXM ) share price has fared very poorly over the last month, falling by a substantial 25...